- Home
- EXEL vs MUSA Comparison
EXEL vs MUSA Comparison
Compare EXEL & MUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- MUSA
- Stock Information
- Founded
- EXEL 1994
- MUSA 1996
- Country
- EXEL United States
- MUSA United States
- Employees
- EXEL N/A
- MUSA N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- MUSA Retail-Auto Dealers and Gas Stations
- Sector
- EXEL Health Care
- MUSA Consumer Discretionary
- Exchange
- EXEL Nasdaq
- MUSA Nasdaq
- Market Cap
- EXEL 9.7B
- MUSA 10.4B
- IPO Year
- EXEL 2000
- MUSA N/A
- Fundamental
- Price
- EXEL $36.20
- MUSA $475.94
- Analyst Decision
- EXEL Buy
- MUSA Hold
- Analyst Count
- EXEL 17
- MUSA 5
- Target Price
- EXEL $35.50
- MUSA $509.40
- AVG Volume (30 Days)
- EXEL 2.5M
- MUSA 166.5K
- Earning Date
- EXEL 02-04-2025
- MUSA 02-05-2025
- Dividend Yield
- EXEL N/A
- MUSA 0.40%
- EPS Growth
- EXEL 441.02
- MUSA 2.41
- EPS
- EXEL 1.55
- MUSA 24.23
- Revenue
- EXEL $2,081,598,000.00
- MUSA $18,275,200,000.00
- Revenue This Year
- EXEL $20.53
- MUSA $9.53
- Revenue Next Year
- EXEL $0.95
- MUSA $2.57
- P/E Ratio
- EXEL $23.39
- MUSA $19.66
- Revenue Growth
- EXEL 17.31
- MUSA N/A
- 52 Week Low
- EXEL $20.02
- MUSA $350.55
- 52 Week High
- EXEL $37.59
- MUSA $561.08
- Technical
- Relative Strength Index (RSI)
- EXEL 58.54
- MUSA 29.59
- Support Level
- EXEL $33.05
- MUSA $469.67
- Resistance Level
- EXEL $37.59
- MUSA $496.04
- Average True Range (ATR)
- EXEL 0.99
- MUSA 11.61
- MACD
- EXEL 0.28
- MUSA -2.09
- Stochastic Oscillator
- EXEL 69.38
- MUSA 15.27
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About MUSA Murphy USA Inc.
Murphy USA Inc is an American retailer of gasoline products and convenience-store merchandise operating in the United States. The stores are 100% company-operated and 90% company-owned; most are adjacent to Walmart stores. The business also contains product supply and wholesale assets, such as product distribution terminals and pipelines. Murphy is positioned in the market as a low-price, high-volume fuel retailer selling through low-cost kiosks and small stores. The stores adjacent to Walmart offer a discount program. The amount of the discount offered can vary based on many factors, including state laws.